hydrazine has been researched along with Venous Thrombosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherif, H; Chowdhury, O; Garelius, H; Hellström-Lindberg, E; Jacobsen, SE; Lorenz, F; Saft, L; Svensson, T | 1 |
| Barcellini, W; Cantoni, S; Caparrotti, G; Carpenedo, M; Carrai, V; Crea, E; Di Nicola, M; Di Renzo, N; Fanin, R; Ferla, V; Liberati, AM; Paoloni, F; Santoro, C; Simonetti, F; Tuniz, E; Veneri, D; Volpetti, S; Zaja, F | 1 |
| Barsam, S; Bussel, JB; Ghanima, W; Lee, SY; Miller, A; Sandset, PM | 1 |
| Akay, OM; Andic, N; Gunduz, E; Şahin, D; Teke, HÜ | 1 |
1 trial(s) available for hydrazine and Venous Thrombosis
| Article | Year |
|---|---|
A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Azacitidine; Benzoates; Blood Platelets; Cell Cycle; Drug Synergism; Drug Therapy, Combination; Female; Hematopoietic Stem Cells; Humans; Hydrazines; Ischemic Attack, Transient; Male; Middle Aged; Myelodysplastic Syndromes; Pilot Projects; Platelet Count; Pyrazoles; Receptors, Thrombopoietin; Remission Induction; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2014 |
3 other study(ies) available for hydrazine and Venous Thrombosis
| Article | Year |
|---|---|
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Benzoates; Combined Modality Therapy; Drug Resistance; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Italy; Male; Middle Aged; Platelet Count; Portal Vein; Postoperative Complications; Premedication; Preoperative Care; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Salvage Therapy; Splenectomy; Thrombophilia; Thrombopoiesis; Thrombopoietin; Venous Thrombosis; Young Adult | 2016 |
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.
Topics: Benzoates; Blood Coagulation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemorrhage; Humans; Hydrazines; Platelet Count; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Thrombophilia; Thrombopoietin; Venous Thrombosis | 2012 |
Cardiac and pulmonary thrombosis during multidrug treatment in an idiopathic thrombocytopenic purpura patient.
Topics: Adult; Benzoates; Danazol; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Methylprednisolone; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Venous Thrombosis; Vincristine | 2014 |